Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.

By exploiting the genetic variation in cancer cells, an already approved cancer drug demonstrated enhanced effects against cancer cells in specific patient groups.

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.

A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...

Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

With a federal grant in hand, researchers at the health system and national lab will try to hit fast forward on the long and ...

The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with ...

The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Researchers from Auburn University, partnering with the University of Basel in Switzerland, have discovered a new way to make ...

Scientists at Auburn University have made an important discovery that could improve cancer treatments. Just like a coach ...